Table 5.
Anti-HBs concentrations (mIU/ml) after all HBV doses in subjects who were non-responders to hepatitis B at the end of the primary and booster studies.
| Post Extra HBV | HBV | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gestational age (Weeks) | Birth weight (kg) | Percentile at birth | Weight at 1st vaccination (kg) | Percentile at 6 months | Weight at 6 months (kg) | Pre-primary | Post-primary | Pre-booster | Post-booster | Dose 1 | Dose 2 | Dose 3 | Persistence at 4 years (mIU/ml) |
| 33 | 2.1 | 75 | 4.4 | 95 | 8.3 | <10 | <10 | <10 | <10 | 690 | 3485 | NG | 176 |
| 35 | 2.0 | 25 | 4 | 25 | 6.7 | <10 | <10 | <10 | <10 | <10 | <10 | 32 | 128 |
| 32 | 0.6 | <10 | 1.7 | <5 | 4.4 | <10 | <10 | <10 | <10 | <10 | 141 | NG | 64 |
| 31 | 0.8 | <10 | 1.7 | 10 | 5.1 | 97 | <10 | <10 | <10 | <10 | NA | NG | <10 |
| 33 | 2.0 | 50 | 4.3 | >90 | 8.4 | <10 | <10 | <10 | <10 | <10 | <10 | <10 | <10 |
| 35 | 1.7 | 10 | 3.6 | 50 | 6.6 | <10 | <10 | <10 | <10 | <10 | 1087 | NG | NA |
NA = Not available; NG = Not given.